Keywords
comparative oncology
immunohistochemistry
N-cadherin
oestrogen receptors
How to Cite
Abstract
Canine mammary tumors (CMTs) are among those most frequently diagnosed in intact female dogs. They share biological and hormonal similarities with human breast cancer, which renders them valuable models in comparative oncology. This study aimed to evaluate the clinical, histopathological, and immunohistochemical characteristics of CMTs in intact female dogs. A total of 22 archived CMT cases submitted between 2013 and 2023 was conducted at the Federal University of Agriculture, Abeokuta. Samples were obtained through mastectomy or nodulectomy from female dogs presented at private veterinary clinics and a teaching hospital. Clinical data, including age, tumour size, location, lymph node involvement, and spay status, were recorded. Most dogs were German Shepherds (45.5%) with a mean age of 8.15 years; none were spayed. The tumours were predominantly malignant (77.3%) and commonly located in the inguinal mammary glands (40.9%). Stage T2 (45.5%) and histological grade II (72.7%) were the most prevalent. E-cadherin was immunopositive in 89% of tumours, with stronger expression in malignant cases. N-cadherin expression was significantly associated with malignancy (p = 0.001), indicating epithelial-mesenchymal transition (EMT). Oestrogen receptors α (Orα) was strongly expressed in all tumours, with significantly higher levels in cases of malignancy (p = 0.002). Progesterone receptor (PR) and vimentin were observed only in malignant tumours, while Ki-67 showed mild, non-significant expression. These findings suggest that N-cadherin, ORα, and PR may serve as potential biomarkers of malignancy and hormonal responsiveness in CMTs. They also support the relevance of molecular profiling in the diagnosis and management of canine mammary tumours.
References
Allred, D., Harvey, J., Berardo, M., Clark, G. 1998. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathology, 11, 2, 155-168.
Arihiro, K., Oda, M., Ogawa, K., Tominaga, K., Kaneko, Y. et al. 2010. Comparison of evaluations of hormone receptors in breast carcinoma by image-analysis using three automated immunohistochemical stainings. Experimental Therapeutics and Medicine, 1: 927-932. https://doi.org/10.3892/etm.2010.142
Benavente, M.A., Bianchi, C.P., Aba, M.A. 2019. Expression of oxytocin receptors in canine mammary tumours. Journal of Comparative Pathology, 170, 26-33. https://doi.org/10.1016/j.jcpa.2019.05.005
Brønden, L.B., Nielsen, S.S., Toft, N., Kristensen, A.T. 2010. Data from the Danish veterinary cancer registry on the occurrence and distribution of neoplasms in dogs in Denmark. Veterinary Record, 166, 19, 586–590. https://doi.org/10.1136/vr.b4808
Carvalho, M.I., Guimarães, M.J., Pires, I., Prada, J., Silva-Carvalho, R., Lopes, C., Queiroga, F.L. 2013. EGFR and microvessel density in canine malignant mammary tumours. Research in Veterinary Science, 95, 3, 1094-9. https://doi.org/10.1016/j.rvsc.2013.09.003
Cassali, G.D., Lavalle, G.E., Ferreira, E., Estrela-Lima, A., De Nardi, A.B., Ghever, C., Sobral, R.A., Amorim, R.L., Oliveira, L.O., Sueiro, F.A.R., Beserra, H.E.O., Bertagnolli, A.C., Gamba, C.O., Damasceno, K.A., Campos, C.B., Araujo, M.R., Campos, L.C., Monteiro, L.N., Nunes, F.C., Horta, R.S., Reis, D.C., Luvizotto, M.C.R., Magalhães, G.M., Raposo, J.B., Ferreira, A.M.R., Tanaka, N.M., Grandi, F., Ubukata, R., Batschinski, K., Terra, E.M., Salvador, R.C.L., Jark, P.C., Delecrodi, J.E.R., Nascimento, N.A., Silva, D.N., Silva, L.P., Ferreira, K.C.R.S., Frehse, M.S., di Santis, G.W., Silva, E.O., Guim, T.N., Kerr, B., Cintra, P.P., Silva, F.B.F., Leite, J.S., Mello, M.F.V., Ferreira, M.L.G., Fukumasu, H., Salgado, B.S., Torres, R. 2014. Consensus for the diagnosis, prognosis and treatment of canine mammary tumors. Brazilian Journal of Veterinary Pathology, 6, 2, 38–69.
Chang, S.C., Chang, C.C., Chang, T.J., Wong, M.L. 2005. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998–2002). Journal of the American Veterinary Medical Association, 227, 10, 1625–1629. https://doi.org/10.2460/javma.2005.227.1625
Chang, C., Tsai, M., Liao, J., Peng-Weng Chan, J., Wong, M.L., Chang, S.C. 2009. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumours. Journal of American Veterinary Medical Association, 235, 4, 391– 396. https://doi.org/10.2460/javma.235.4.391
Dongre, A., Weinberg, R.A. 2019. New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer. Nature Reviews Molecular Cell Biology, 20, 2, 69–84. https://doi.org/10.1038/s41580-018-0080-4
Gama, A., Paredes, J., Gärtner, F., Alves, A., Schmitt, F. 2008. Expression of E-cadherin, P-cadherin and β-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. The Veterinary Journal, 177, 1, 45–53. https://doi.org/10.1016/j.tvjl.2007.05.024
Gartner, F., Geraldes, M., Cassali, G., Rema, A., Schmitt, F. 1999. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis. Veterinary Journal, 158: 39-47. https://doi.org/10.1053/tvjl.1998.0333
Goebel, K., Merner, N. 2017. A monograph proposing the use of canine mammary tumour as a model for the study of hereditary breast cancer susceptibility genes in humans. Veterinary Medical Science, 3, 2, 51-62. https://doi.org/10.1002/vms3.61
Goldschmidt, M., Peña, L., Rasotto, R., Zappulli, V. 2011. Classification and grading of canine mammary tumors. Veterinary Pathology, 48, 1, 117–131 https://doi.org/10.1177/0300985810393258
Hussain, S., Saxena, S., Shrivastava, R., Arora, R., Singh, S., Jena, N., Kumar, A., Sharma, M., Sahoo, A., Tiwari A.K., Mishra, B.P., Singh, R.K. 2018. Multiplexed auto-antibody signature for serological detection of canine mammary tumours. Scientific reports, 8, 1, 15785. https://doi.org/10.1038/s41598-018-34097-0
Karayannopoulou, M., Kaldrymidou, E., Constantinidis, T.C., Dessiris, A. 2005. Histological grading and prognosis in dogs with mammary carcinomas: Application of a human grading method. Journal of Comparative Pathology, 133, 4, 246–252. https://doi.org/10.1016/j.jcpa.2005.05.003
Kumar, A., Singh, S., Saxena, S., Lakshmanan, K., Sangaiah, A., Chauhan, H., Shrivastava, S., Singh, R. 2019. Deep feature learning for histopathological image classification of canine mammary tumours and human breast cancer. Information Sciences, 508: 405-421. https://doi.org/10.1016/j.ins.2019.08.072
Kurzman I., Gilbertson S. 1986. Prognostic factors in canine mammary tumours, Seminar of Veterinary Medicine and Surgery (Small Animal), 1, 1, 25–32.
Leonel, C., Borin, T., de Carvalho Ferreira, L., Moschetta, M., Bajgelman, M., Viloria-Petit, A., de Campos Zuccari, D. 2017. Inhibition of epithelial-mesenchymal transition and metastasis by combined TGF beta knockdown and metformin treatment in a canine mammary cancer xenograft model. Journal of Mammary Gland Biology and Neoplasia, 22, 1, 27-41. https://doi.org/10.1007/s10911-016-9370-7
Lopuszyński, W., Szczubiał, M., Millán, Y., Guil-Luna, S., Sánchez-Céspedes, R., de las Mulas, J., Śmiech, A., Bulak, A. 2019. Immunohistochemical expression of p63 protein and calponin in canine mammary tumours. Research in Veterinary Science, 123: 232–238. https://doi.org/10.1016/j.rvsc.2019.01.017
Łopuszyński, W., Szczubiał, M., Klimiuk, P., Śmiech, A., Dąbrowski, R., Bochniarz, M. 2015. Immunohistochemical evaluation of E-cadherin expression in normal and neoplastic canine mammary glands. Medycyna Weterynaryjna, 71, 3, 152-157.
Markov, D, Poryazova, E, Raycheva, R, Markov, G. 2024. Expression of HIF-1α, Ki67, SMA and E-cadherin in endometriosis, endometrial and ovarian carcinoma. Folia Medica (Plovdiv), 66, 1, 97-103. https://doi.org/10.3897/folmed.66.e112757
Millanta, F., Calandrella, M., Bari, G., Niccolini, M., Poli, A. 2005. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Research in Veterinary Science, 79, 3, 225–232. https://doi.org/10.1016/j.rvsc.2005.02.002
Nieto, A., Peña, L., Pérez-Alenza, M. D., Sánchez, M. A., Flores, J. M., Castaño, M. 2000. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: Clinical and pathologic associations and prognostic significance. Veterinary Pathology, 37, 3, 239–247. https://doi.org/10.1354/vp.37-3-239
Pena, L., Gama, A., Goldschmidt, M., Abadie, J., Benazzi, C., Castagnaro, M., Diez, L., Gartner, F., Hellmen, E., Kiupel, M., Millan, M., Nguyen, F., Poli, A., Sali, G., Zappulli, N., de las Mulas, J. 2014. Canine mammary tumours: A review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER 2, and hormone receptor assessment using immunohistochemistry. Veterinary Pathology, 51, 1, 127-145. https://doi.org/10.1177/0300985813509388
Pérez Alenza, M.D., Peña, L., Nieto, A.I,. Castaño, M. 1997. Clinical and pathological prognostic factors in canine mammary tumors. Annali dell’Istituto Superiore di Sanità. 33, 4, 581-585.
Ranieri, G., Gadaleta, C., Patruno, R., Zizzo, N., Daidone, M., Hansson, M., Paradisso, A., Ribatti, D. 2013. A model of study for human cancer spontaneous occurring tumours in dogs. Biological features and translation for new anticancer therapies. Critical reviews in oncology/hematology, 88, 1, 187-197. https://doi.org/10.1016/j.critrevonc.2013.03.005
Salaritabar, A., Berindan-Neagoe, I., Darvish, B., Hadjiakhoondi, F., Manayi, A., Devi, K., Barreca, D., Orhan, I., Süntar, I., Farooqi, A., Gulei, D., Nabavi, S.F., Sureda, A., Daglia, M., Dehpour, A.R., Nabavi, S.M., Shirooie, S. 2019. Targeting Hedgehog signaling pathway: Paving the road for cancer therapy. Pharmacology Research, 141, 466-480. https://doi.org/10.1016/j.phrs.2019.01.014
Sánchez-Céspedes, R., Suárez-Bonnet, A., Millán, Y., Guil-Luna, S., Reymundo, C., Espinosa de los Monteros, A., Martin de las Mulas, J. 2013. Use of CD10 as a marker of canine mammary myoepithelial cells. Veterinary Journal, 195, 2, 192–199. https://doi.org/10.1016/j.tvjl.2012.06.003
Sleeckx, N., de Rooster; H., Veldhuis, Kroeze, E. J., Van Ginneken, C., Van Brantegem, L. 2011. Canine mammary tumours, an overview. Reproduction in Domestic Animals, 46, 6, 1112–1131. https://doi.org/10.1111/j.1439-0531.2011.01797.x
Sorenmo, K. 2003. Canine mammary gland tumors. Veterinary Clinic North America Small Animal Practice, 33, 573–96. https://doi.org/10.1016/S0195-5616(03)00020-2
Sorenmo K., Worley D., Goldschmidt M. 2013. Tumours of the mammary gland, In Withrow and MacEwen’s Small Animal Clinical Oncology. Eds. S. Withrow, D. Vali, R. Page, 5th edition, Elsevier, St. Louism. M, 538-556. https://doi.org/10.1016/B978-1-4377-2362-5.00027-X
Terzaghi, L., Banco, B., Groppetti, D., Priscila, C., Dall'Acquac, C., Pecile, A., Grieco, V., Lodde, V., Luciano, A.M. 2020. Progesterone receptor membrane component 1 (PGRMC1) expression in canine mammary tumours: A preliminary study. Research in Veterinary Science, 132: 101–107. https://doi.org/10.1016/j.rvsc.2020.06.004
Vascellari, M., Capelloa, K., Carminato, A., Zanardello, C., Baioni, E., Mutinelli, F. 2016. Incidence of mammary tumours in the canine population living in the Veneto region (Northeastern Italy): Risk factors and similarities to human breast cancer. Preventive Veterinary Medicine, 126: 183-189. https://doi.org/10.1016/j.prevetmed.2016.02.008
Yoshida, K., Yoshida, S., Choisunirachon, N., Saito, T., Matsumoto, K., Saeki, K., Mochizuki, M., Nishimura, R., Sasaki, N., Nakagawa, T. 2014. The relationship between clinicopathological features and expression of epithelial and mesenchymal markers in spontaneous canine mammary gland tumors, Journal of Veterinary Medical Science, 76, 10, 1321-1327. https://doi.org/10.1292/jvms.14-0104
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Temitope Oladipo, Lawrence, Temidayo, Musa